203 related articles for article (PubMed ID: 23558050)
1. An international assessment of ovarian cancer incidence and mortality.
Lowe KA; Chia VM; Taylor A; O'Malley C; Kelsh M; Mohamed M; Mowat FS; Goff B
Gynecol Oncol; 2013 Jul; 130(1):107-14. PubMed ID: 23558050
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and incidence of comorbidities in elderly women with ovarian cancer.
Chia VM; O'Malley CD; Danese MD; Lindquist KJ; Gleeson ML; Kelsh MA; Griffiths RI
Gynecol Oncol; 2013 May; 129(2):346-52. PubMed ID: 23422502
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of low-grade serous ovarian cancer.
Plaxe SC
Am J Obstet Gynecol; 2008 Apr; 198(4):459.e1-8; discussion 459.e8-9. PubMed ID: 18395040
[TBL] [Abstract][Full Text] [Related]
5. Ovarian and endometrial cancers.
Mant JW; Vessey MP
Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer incidence in the United States, 1992-1999.
Quirk JT; Natarajan N
Gynecol Oncol; 2005 May; 97(2):519-23. PubMed ID: 15863154
[TBL] [Abstract][Full Text] [Related]
7. International variations in bladder cancer incidence and mortality.
Chavan S; Bray F; Lortet-Tieulent J; Goodman M; Jemal A
Eur Urol; 2014 Jul; 66(1):59-73. PubMed ID: 24451595
[TBL] [Abstract][Full Text] [Related]
8. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
9. Decline in breast cancer incidence--United States, 1999-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Jun; 56(22):549-53. PubMed ID: 17557070
[TBL] [Abstract][Full Text] [Related]
10. Survival among U.S. women with invasive epithelial ovarian cancer.
McGuire V; Jesser CA; Whittemore AS
Gynecol Oncol; 2002 Mar; 84(3):399-403. PubMed ID: 11855877
[TBL] [Abstract][Full Text] [Related]
11. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000.
Singh GK; Miller BA; Hankey BF; Edwards BK
Cancer; 2004 Sep; 101(5):1051-7. PubMed ID: 15329915
[TBL] [Abstract][Full Text] [Related]
12. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.
Schrag D; Earle C; Xu F; Panageas KS; Yabroff KR; Bristow RE; Trimble EL; Warren JL
J Natl Cancer Inst; 2006 Feb; 98(3):163-71. PubMed ID: 16449676
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer incidence and mortality--United States, 1992.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Oct; 45(39):833-7. PubMed ID: 8864142
[TBL] [Abstract][Full Text] [Related]
14. Why have ovarian cancer mortality rates declined? Part I. Incidence.
Sopik V; Iqbal J; Rosen B; Narod SA
Gynecol Oncol; 2015 Sep; 138(3):741-9. PubMed ID: 26080287
[TBL] [Abstract][Full Text] [Related]
15. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
[TBL] [Abstract][Full Text] [Related]
16. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
Jemal A; Ward E; Thun MJ
Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
[TBL] [Abstract][Full Text] [Related]
17. Global trends in breast cancer incidence and mortality 1973-1997.
Althuis MD; Dozier JM; Anderson WF; Devesa SS; Brinton LA
Int J Epidemiol; 2005 Apr; 34(2):405-12. PubMed ID: 15737977
[TBL] [Abstract][Full Text] [Related]
18. Why have ovarian cancer mortality rates declined? Part II. Case-fatality.
Sopik V; Iqbal J; Rosen B; Narod SA
Gynecol Oncol; 2015 Sep; 138(3):750-6. PubMed ID: 26080288
[TBL] [Abstract][Full Text] [Related]
19. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
[TBL] [Abstract][Full Text] [Related]
20. Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis.
Abdollah F; Gandaglia G; Thuret R; Schmitges J; Tian Z; Jeldres C; Passoni NM; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI; Sun M
Cancer Epidemiol; 2013 Jun; 37(3):219-25. PubMed ID: 23485480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]